CClinicalTrials.gg
CompletedNCT04634864TIPSUpdated Nov 18, 2020

Transcranial Direct Current Stimulation in Post-stroke Fatigue

An interventional study of Anodal tDCS and sham tDCS in Fatigue and Stroke, sponsored by University College, London. Completed at 1 site in United Kingdom. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2020-11-18.

Sponsored by University College, London · Not applicable, Interventional, and Basic science

From the registry’s dates

  • Registered 2 years 10 months after the study started (first participant enrolled Jan 2018, registered Nov 2020).
Phase
Not applicable
Study type
Interventional
Enrollment
33
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This is a double-blind, sham-controlled, anodal tDCS study to understand the effect of increasing motor cortex excitability on post-stroke fatigue.

02

Conditions studied

  • Fatigue
  • Stroke

Browse trials for

03

In context

Stroke

7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.

This study's enrollment of 33 is below the median of 50 across 5,369 interventional studies indexed under Stroke.

Browse Stroke studies →

Lead sponsor

University College, London is the lead sponsor of 632 studies on the registry; 145 are open to participants now.

Of its 6 completed or terminated interventional studies of FDA-regulated products, 2 (33%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

Diagnosed with stroke at least 3 months post-stroke

Exclusion criteria

Exclusion Criteria:

Other neurological conditions on Anti-depressants severe motor impairment (affected hand grip \<60% unaffected hand) severe cognitive impairment (unable to follow instructions, or give informed consent) scored >11 in the depression sub-section of HADS questionnaire contraindications for TMS or tES

05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Outcomes assessor)
Enrollment
33 participants (actual)

Study arms

  • Active comparator
    Anodal tDCS

    40 minutes of 2mA intensity direct current stimulation

    Device: Anodal tDCS

  • Sham comparator
    sham tDCS

    40 minutes of 0mA intensity. the session starts with a ramp up to 2mA, but machine is switched off after 2 minutes of stimulation.

    Device: sham tDCS

Interventions

  • DeviceAnodal tDCS

    40 minutes of 2mA intensity direct current stimulation was delivered over both the right and left motor cortex simultaneously

  • Devicesham tDCS

    The stimulator was switched off after 2 minutes of stimulation.

06

What researchers measure

Primary outcomes

  1. Fatigue Severity Scale - 7

    a questionnaire based fatigue scale

    Time frame: 2 weeks

Secondary outcomes

  1. Resting Motor Threshold

    This is a measure of cortical excitability as measured by transcranial magnetic stimulation

    Time frame: 1 day

  2. Input-output curves

    This is a measure of cortical recruitment as measured by transcranial magnetic stimulation

    Time frame: 1 day

  3. Perceived effort - Explicit

    A VAS scale associated with a grip task

    Time frame: 1 day

  4. Perceived effort - Implicit

    A novel line length estimation task

    Time frame: 1 day

07

Study locations

1 site
  • 33 Queen Square, Institute of Neurology, UCL
    London, WC1N 3BG, United Kingdom
08

References and documents

Publications

  • De Doncker W, Ondobaka S, Kuppuswamy A. Effect of transcranial direct current stimulation on post-stroke fatigue. J Neurol. 2021 Aug;268(8):2831-2842. doi: 10.1007/s00415-021-10442-8. Epub 2021 Feb 17. PubMed 33598767 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 18, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04634864
Lead sponsor
University College, London
Responsible party
Sponsor
First posted
Nov 18, 2020
Start date
Jan 10, 2018
Primary completion
Aug 8, 2019
Completion
Aug 8, 2019
Last update
Nov 18, 2020

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Nov 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion